These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21434854)

  • 41. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
    PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
    Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.
    Galina A
    Int J Biochem Cell Biol; 2014 Sep; 54():266-71. PubMed ID: 24842108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncogenes strike a balance between cellular growth and homeostasis.
    Qiu B; Simon MC
    Semin Cell Dev Biol; 2015 Jul; 43():3-10. PubMed ID: 26277544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment.
    Daurio NA; Tuttle SW; Worth AJ; Song EY; Davis JM; Snyder NW; Blair IA; Koumenis C
    Cancer Res; 2016 Jun; 76(11):3295-306. PubMed ID: 27020861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.
    Shinohara H; Taniguchi K; Kumazaki M; Yamada N; Ito Y; Otsuki Y; Uno B; Hayakawa F; Minami Y; Naoe T; Akao Y
    Cancer Lett; 2015 Apr; 360(1):28-38. PubMed ID: 25644089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. YL4073 is a potent autophagy-stimulating antitumor agent in an in vivo model of Lewis lung carcinoma.
    Xu YZ; Li YH; Lu WJ; Lu K; Wang CT; Li Y; Lin HJ; Kan LX; Yang SY; Wang SY; Zhao YL
    Oncol Rep; 2016 Apr; 35(4):2081-8. PubMed ID: 26847587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Galangin induced antitumor effects in human kidney tumor cells mediated via mitochondrial mediated apoptosis, inhibition of cell migration and invasion and targeting PI3K/ AKT/mTOR signalling pathway.
    Zhu Y; Rao Q; Zhang X; Zhou X
    J BUON; 2018; 23(3):795-799. PubMed ID: 30003754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pivotal role of MicroRNAs in glucose metabolism in cancer.
    Taefehshokr S; Taefehshokr N; Hemmat N; Hajazimian S; Isazadeh A; Dadebighlu P; Baradaran B
    Pathol Res Pract; 2021 Jan; 217():153314. PubMed ID: 33341548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
    Rodrik V; Zheng Y; Harrow F; Chen Y; Foster DA
    Mol Cell Biol; 2005 Sep; 25(17):7917-25. PubMed ID: 16107734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
    Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
    Ooi AT; Gomperts BN
    Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promising strategy developed to target drug-resistant cancer cells.
    Thorne J
    Future Med Chem; 2014 Apr; 6(6):603. PubMed ID: 25028759
    [No Abstract]   [Full Text] [Related]  

  • 59. GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt.
    Altomare DA; Zhang L; Deng J; Di Cristofano A; Klein-Szanto AJ; Kumar R; Testa JR
    Clin Cancer Res; 2010 Jan; 16(2):486-96. PubMed ID: 20075391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.
    Maschinot CA; Pace JR; Hadden MK
    Curr Med Chem; 2015; 22(35):4033-57. PubMed ID: 26310919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.